Clinical Trials Browser

OTHER × Triple Negative Breast Neoplasms × epalrestat × Clear all

NCT03244358 2021-01-29

Evaluation of Epalrestat in Metastatic Triple-negative Breast Cancer

Phase 2 Terminated

Triple Negative Breast Neoplasms